NEW YORK, Aug. 31, 2023 /PRNewswire/ -- The
sex reassignment surgery market in US is to grow by
USD 125.78 million from 2022 to 2027 progressing at a
CAGR of 10.84% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.
The market is driven by an increase in the number of people opting for sex change surgeries in the US. The number of transgender surgeries performed each year in the US ranges from 100 to 500. According to the 2020 plastic surgery statistics provided by ASPS, transgender women have undergone 6,368 gender confirmation surgeries. in the US, compared with 5,616 in 2019. In addition, 1,231 genital surgery transgender surgeries, 4,035 thoracoscopic or thoracoscopic surgeries, and 1,102 facial surgeries were performed in 2020. Hence, these factors are expected to drive market growth during the forecast period. -
Here is an Exclusive report talking about Market scenarios with a historical period (2017-2021) and forecast period (2023-2027). Download Sample Report in minutes!
Continue Reading
Technavio has announced its latest market research report titled Sex Reassignment Surgery Market in US
The report on the sex reassignment surgery market in the US provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as company analysis.
Sex Reassignment Surgery Market In US 2023-2027 - Market Dynamics
Major Trend The rising awareness among the transgender population about sex reassignment surgeries is a major trend in the market. In the US, the need for sex reassignment surgery has increased significantly. Increased visibility has improved society's understanding and acceptance of transgender people through the introduction of social media. In addition, counseling services are also offered in the market to address the negative impact of gender dysphoria in their lives, help patients discover their gender identity, and promote resilience. Hence, these factors are expected to drive market growth during the forecast period.
Significant Challenge - Side effects of sex reassignment surgeries are a significant challenge in restraining the market growth.
Drivers, Trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!
Sex Reassignment Surgery Market In US 2023-2027: Market Segmentation
The sex reassignment surgery market in US analysis includes the type (male to female and female to male), and end-user (hospitals and clinics)
The market share growth by the
male-to-female segment will be significant during the forecast period. Male-to-female sex reassignment surgery is the transformation of male genitalia into a shape that has the appearance and to some extent function of female genitalia. Patients are treated with female hormones before surgery to look more feminine. Orchiectomy, which includes the removal of the testicle, is one of the main processes involved in sex reassignment surgery between men and women. Hence, such factors are expected to drive the growth of this segment during the forecast period.
This report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters-
View Sample Report
Companies Mentioned
Boston Childrens Hospital
Boston Medical Center
Cedars Sinai Health System
CNY Cosmetic and Reconstructive Surgery
Cornell University
Denver Health
Harvard University
Icahn School of Medicine at Mount Sinai
Mass General Brigham Inc.
Moein Surgical Arts
NorthWestern University
Oregon Health and Science University
Plastic Surgery Group of Rochester
Regents of the University of Michigan
Stanford University
The Cleveland Clinic Foundation
The Johns Hopkins Health System Corp.
The Regents of the University of California
The University of Utah
Transgender Surgery Institute
For more insights Buy Report now!
Company Offering
Moein Surgical Arts - The company offers sex reassignment surgery, such as male-to-female gender reassignment surgery.
Cedars Sinai Health System - The company offers sex reassignment surgery, such as bilateral orchiectomy.
Denver Health - The company offers sex reassignment surgery, such as orchiectomy.
Gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Related Reports:
The
hereditary angioedema (HAE) therapeutics market is estimated to grow by USD 1,647.38 million at a CAGR of 8.95% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by end-user (hospital pharmacies, retail pharmacies, and e-commerce), product (C1-esterase inhibitor, bradykinin B2 receptor antagonist, kallikrein inhibitor, and others), geography (North America, Europe, Asia, and the Rest of the World (ROW)). The growing demand for personalized medicine is a major trend in the market.
The
photodynamic therapy market is estimated to grow by USD 2,053.68 million at a CAGR of 8.22% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by application (cancer, actinic keratosis, psoriasis, acne, and others), product (photosensitizer drugs, and photodynamic therapy devices), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). Early detection of cancer is a key factor driving the market growth during the forecast period.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End User
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Company Landscape
12 Company Analysis
13 Appendix
About US
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website:
SOURCE Technavio